The pharmacokinetic–pharmacodynamic approach to a rational dosage regimen for antibiotics PL Toutain, JRE Del Castillo, A Bousquet-Mélou Research in veterinary science 73 (2), 105-114, 2002 | 469 | 2002 |
Plasma terminal half‐life PL Toutain, A Bousquet‐mélou Journal of veterinary pharmacology and therapeutics 27 (6), 427-439, 2004 | 398 | 2004 |
Pharmacodynamics and pharmacokinetics of nonsteroidal anti‐inflammatory drugs in species of veterinary interest P Lees, MF Landoni, J Giraudel, PL Toutain Journal of veterinary pharmacology and therapeutics 27 (6), 479-490, 2004 | 395 | 2004 |
Plasma clearance PL Toutain, A Bousquet‐mélou Journal of veterinary pharmacology and therapeutics 27 (6), 415-425, 2004 | 349 | 2004 |
Bioavailability and its assessment PL Toutain, A Bousquet‐mélou Journal of veterinary pharmacology and therapeutics 27 (6), 455-466, 2004 | 335 | 2004 |
Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure JA Taylor, FS Vom Saal, WV Welshons, B Drury, G Rottinghaus, PA Hunt, ... Environmental health perspectives 119 (4), 422-430, 2011 | 327 | 2011 |
Species differences in pharmacokinetics and pharmacodynamics PL Toutain, A Ferran, A Bousquet-Mélou Comparative and veterinary pharmacology, 19-48, 2010 | 288 | 2010 |
Volumes of distribution PL Toutain, A Bousquet‐mélou Journal of veterinary pharmacology and therapeutics 27 (6), 441-453, 2004 | 282 | 2004 |
Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine PL Toutain, P Lees Journal of veterinary pharmacology and therapeutics 27 (6), 467-477, 2004 | 265 | 2004 |
Holding thermal receipt paper and eating food after using hand sanitizer results in high serum bioactive and urine total levels of bisphenol A (BPA) AM Hormann, FS Vom Saal, SC Nagel, RW Stahlhut, CL Moyer, ... PloS one 9 (10), e110509, 2014 | 237 | 2014 |
The pharmacokinetics of xylazine hydrochloride: an interspecific study R GARCIA‐VILLAR, PL Toutain, M Alvinerie, Y Ruckebusch Journal of veterinary pharmacology and therapeutics 4 (2), 87-92, 1981 | 218 | 1981 |
Plasma exogenous creatinine clearance test in dogs: comparison with other methods and proposed limited sampling strategy ADJ Watson, HP Lefebvre, D Concordet, V Laroute, JP Ferré, JP Braun, ... Journal of Veterinary Internal Medicine 16 (1), 22-33, 2002 | 182 | 2002 |
Creatine kinase in the dog: a review M Aktas, D Auguste, HP Lefebvre, PL Toutain, JP Braun Veterinary research communications 17, 353-369, 1993 | 166 | 1993 |
Comparative pharmacokinetics of doramectin and ivermectin in cattle PL Toutain, DW Upson, TN Terhune, ME McKenzie Veterinary Parasitology 72 (1), 3-8, 1997 | 158 | 1997 |
En route towards European clinical breakpoints for veterinary antimicrobial susceptibility testing: a position paper explaining the VetCAST approach PL Toutain, A Bousquet-Mélou, P Damborg, AA Ferran, D Mevius, ... Frontiers in microbiology 8, 2344, 2017 | 149 | 2017 |
High bioavailability of bisphenol A from sublingual exposure V Gayrard, MZ Lacroix, SH Collet, C Viguié, A Bousquet-Melou, ... Environmental health perspectives 121 (8), 951-956, 2013 | 142 | 2013 |
Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling PL Toutain, A Autefage, C Legrand, M Alvinerie Journal of veterinary pharmacology and therapeutics 17 (6), 459-469, 1994 | 142 | 1994 |
Free drug fraction vs. free drug concentration: a matter of frequent confusion. PL Toutain, A Bousquet-Mélou Journal of Veterinary Pharmacology & Therapeutics 25 (6), 2002 | 139 | 2002 |
Should oral gavage be abandoned in toxicity testing of endocrine disruptors? LN Vandenberg, WV Welshons, FS Vom Saal, PL Toutain, JP Myers Environmental Health 13, 1-7, 2014 | 138 | 2014 |
Comparison of pharmacokinetic profiles of doramectin and ivermectin pour-on formulations in cattle V Gayrard, M Alvinerie, PL Toutain Veterinary Parasitology 81 (1), 47-55, 1999 | 138 | 1999 |